| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| L D Popov. [Effect of kynurenic acid on catecholamine content in the brain of rats with different susceptibility to seizures]. Fiziolohichnyi zhurnal (Kiev, Ukraine : 1994). vol 48. issue 6. 2003-05-15. PMID:12577468. |
the results of a comparison of the absolute contents of catecholamines, as wel las the ratio between the contents of a precursor and the transmitter and the levels of the transmitter in the appropriate nervous terminals are the base to suggest that kynurenic acid enhances the conversion of tyrosine into dopamine, increases its transport to nervous terminals, and decreases the noradrenergic transmission. |
2003-05-15 |
2023-08-12 |
rat |
| Bennett L Lavenstei. Treatment approaches for children with Tourette's syndrome. Current neurology and neuroscience reports. vol 3. issue 2. 2003-04-28. PMID:12583843. |
drug treatment has included dopamine receptor blockers for tics, dopamine agonists, dopamine depletors, and stimulants for attention deficit hyperactivity disorder (adhd), noradrenergic drugs for tics and adhd, serotonergic drugs for ocd, and chemical denervation for involuntary movements with the use of botulinum toxin and stereotactic surgery. |
2003-04-28 |
2023-08-12 |
Not clear |
| Michael D Köhnke, Cyrus P Zabetian, George M Anderson, Werner Kolb, Ines Gaertner, Gerhard Buchkremer, Reinhard Vonthein, Sandra Schick, Ulrich Lutz, Annette M Köhnke, Joseph F Cubell. A genotype-controlled analysis of plasma dopamine beta-hydroxylase in healthy and alcoholic subjects: evidence for alcohol-related differences in noradrenergic function. Biological psychiatry. vol 52. issue 12. 2003-04-10. PMID:12488060. |
a genotype-controlled analysis of plasma dopamine beta-hydroxylase in healthy and alcoholic subjects: evidence for alcohol-related differences in noradrenergic function. |
2003-04-10 |
2023-08-12 |
human |
| Rossella Ventura, Simona Cabib, Antonio Alcaro, Cristina Orsini, Stefano Puglisi-Allegr. Norepinephrine in the prefrontal cortex is critical for amphetamine-induced reward and mesoaccumbens dopamine release. The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 23. issue 5. 2003-03-24. PMID:12629192. |
these results indicate that noradrenergic prefrontal transmission, by allowing increased dopamine release in the nucleus accumbens induced by amphetamine, is a critical factor for the rewarding-reinforcing effects of this drug. |
2003-03-24 |
2023-08-12 |
mouse |
| P Heiser, H Remschmid. [Selective serotonin reuptake inhibitors and newer antidepressive substances in child and adolescent psychiatry]. Zeitschrift fur Kinder- und Jugendpsychiatrie und Psychotherapie. vol 30. issue 3. 2002-12-19. PMID:12227220. |
among these newer groups, characterised by their pharmacological properties, are the serotonin2-antagonists/serotonin reuptake inhibitors (sari), the noradrenergic and specific serotonergic antidepressants (nassa), the noradrenaline and dopamine reuptake inhibitors (ndri) and the serotonin and noradrenaline reuptake inhibitors (snri). |
2002-12-19 |
2023-08-12 |
Not clear |
| E S Vizi, I J Elenko. Nonsynaptic noradrenaline release in neuro-immune responses. Acta biologica Hungarica. vol 53. issue 1-2. 2002-12-04. PMID:12064774. |
besides na released from nonsynaptic varicosities of noradrenergic terminals [92], circulating catecholamines (adrenaline, dopamine, na) are also able to influence immune responses, the production of pro- and anti-inflammatory cytokines by different immune cells. |
2002-12-04 |
2023-08-12 |
Not clear |
| Riina Häidkind, Toomas Kivastik, Marika Eller, Ivo Kolts, Lars Oreland, Jaanus Harr. Denervation of the locus coeruleus projections by treatment with the selective neurotoxin DSP-4 [N (2-chloroethyl)-N-ethyl-2-bromobenzylamine] reduces dopamine release potential in the nucleus accumbens shell in conscious rats. Neuroscience letters. vol 332. issue 2. 2002-11-26. PMID:12384215. |
pretreatment with dsp-4, a neurotoxin highly selective for the locus coeruleus (lc) noradrenergic projections, 2 weeks before in vivo microdialysis in conscious rats had no effect on baseline extracellular dopamine (da) levels in the nucleus accumbens shell, but reduced dose-dependently the dopamine response to depolarisation induced by 50 mm kcl. |
2002-11-26 |
2023-08-12 |
rat |
| C A Cornil, J Balthazart, P Motte, L Massotte, V Seuti. Dopamine activates noradrenergic receptors in the preoptic area. The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 22. issue 21. 2002-11-25. PMID:12417657. |
dopamine activates noradrenergic receptors in the preoptic area. |
2002-11-25 |
2023-08-12 |
Not clear |
| Shaul Schreiber, Avi Bleich, Chaim G Pic. Venlafaxine and mirtazapine: different mechanisms of antidepressant action, common opioid-mediated antinociceptive effects--a possible opioid involvement in severe depression? Journal of molecular neuroscience : MN. vol 18. issue 1-2. 2002-11-08. PMID:11931344. |
among the antidepressants of the newer generations, that involvement occurs only with venlafaxine (a presynaptic drug which blocks the synaptosomal uptake of noradrenaline and serotonin and, to a lesser degree, of dopamine) and with mirtazapine (a postsynaptic drug which enhances noradrenergic and 5-ht1a-mediated serotonergic neurotransmission via antagonism of central alpha-auto- and hetero-adrenoreceptors). |
2002-11-08 |
2023-08-12 |
mouse |
| Maria Antonietta Casu, Dinuccio Dinucci, Giancarlo Colombo, Gian Luigi Gessa, Luca Pan. Reduced DAT- and DBH-immunostaining in the limbic system of Sardinian alcohol-preferring rats. Brain research. vol 948. issue 1-2. 2002-10-30. PMID:12383975. |
since these regions contain both dopamine and noradrenaline (na) fibers, clarification of the dopaminergic and noradrenergic contribution to the decreased th-immunoreactivity was needed. |
2002-10-30 |
2023-08-12 |
rat |
| Maria Antonietta Casu, Dinuccio Dinucci, Giancarlo Colombo, Gian Luigi Gessa, Luca Pan. Reduced DAT- and DBH-immunostaining in the limbic system of Sardinian alcohol-preferring rats. Brain research. vol 948. issue 1-2. 2002-10-30. PMID:12383975. |
to this aim, we carried out the present immunohistochemistry study using two antibodies raised against dopamine beta-hydroxylase (dbh), the enzyme responsible for the conversion of dopamine into noradrenaline, and against the dopamine transporter (dat), as markers for noradrenergic and dopaminergic fibers, respectively. |
2002-10-30 |
2023-08-12 |
rat |
| Heidi E W Day, Nicole M Vittoz, Matthew M Oates, Aldo Badiani, Stanley J Watson, Terry E Robinson, Huda Aki. A 6-hydroxydopamine lesion of the mesostriatal dopamine system decreases the expression of corticotropin releasing hormone and neurotensin mRNAs in the amygdala and bed nucleus of the stria terminalis. Brain research. vol 945. issue 2. 2002-10-25. PMID:12126877. |
although the precise mechanisms are not clear, and the involvement of noradrenergic systems cannot be precluded, data are consistent with the idea that dopamine, released in response to a stressful experience for example, interacts with crh and neurotensin in the extended amygdala to affect emotional responsiveness. |
2002-10-25 |
2023-08-12 |
rat |
| K Yui, S Ikemoto, K Goto, K Nishijima, T Yoshino, T Ishigur. Spontaneous recurrence of methamphetamine-induced paranoid-hallucinatory states in female subjects: susceptibility to psychotic states and implications for relapse of schizophrenia. Pharmacopsychiatry. vol 35. issue 2. 2002-09-25. PMID:11951147. |
thus, noradrenergic hyperactivity and increased dopamine release in response to mild psychosocial stressors may be responsible for the development of flashbacks. |
2002-09-25 |
2023-08-12 |
human |
| L E Bayer, S Kakumanu, C F Mactutus, R M Booze, B J Strup. Prenatal cocaine exposure alters sensitivity to the effects of idazoxan in a distraction task. Behavioural brain research. vol 133. issue 2. 2002-09-19. PMID:12110452. |
the pattern of effects suggests that the differential treatment response to idz on these latter measures resulted from an alteration in norepinephrine (ne)-modulated dopamine release in the coc animals, reflecting lasting changes in dopaminergic and/or noradrenergic systems as a result of the early cocaine exposure. |
2002-09-19 |
2023-08-12 |
human |
| Megumi Adachi, Elaine J Lewi. The paired-like homeodomain protein, Arix, mediates protein kinase A-stimulated dopamine beta-hydroxylase gene transcription through its phosphorylation status. The Journal of biological chemistry. vol 277. issue 25. 2002-07-19. PMID:11943777. |
the homeodomain transcription factor arix/phox2a plays a critical role in the specification of noradrenergic neurons by inducing the expression of dopamine beta-hydroxylase (dbh), the terminal enzyme for noradrenaline biosynthesis. |
2002-07-19 |
2023-08-12 |
Not clear |
| Eugen Davids, Kehong Zhang, Nora S Kula, Frank I Tarazi, Ross J Baldessarin. Effects of norepinephrine and serotonin transporter inhibitors on hyperactivity induced by neonatal 6-hydroxydopamine lesioning in rats. The Journal of pharmacology and experimental therapeutics. vol 301. issue 3. 2002-06-19. PMID:12023542. |
selective dopamine lesions were made using 6-ohda (100 microg, intracisternal) on postnatal day (pd) 5 after desipramine pretreatment (25 mg/kg, s.c.) to protect noradrenergic neurons. |
2002-06-19 |
2023-08-12 |
human |
| Vivienne Ann Russel. Hypodopaminergic and hypernoradrenergic activity in prefrontal cortex slices of an animal model for attention-deficit hyperactivity disorder--the spontaneously hypertensive rat. Behavioural brain research. vol 130. issue 1-2. 2002-05-16. PMID:11864734. |
while electrically stimulated release of dopamine appears to be decreased in prefrontal cortex of shr suggesting hypodopaminergic function, autoreceptor-mediated inhibition of norepinephrine release appears to be impaired in shr, suggesting that noradrenergic function may be poorly regulated in the prefrontal cortex of the shr. |
2002-05-16 |
2023-08-12 |
rat |
| Sharon R Grady, Karen L Murphy, Jian Cao, Michael J Marks, J Michael McIntosh, Allan C Collin. Characterization of nicotinic agonist-induced [(3)H]dopamine release from synaptosomes prepared from four mouse brain regions. The Journal of pharmacology and experimental therapeutics. vol 301. issue 2. 2002-05-13. PMID:11961070. |
release studies in frontal cortex indicated that in this region only dopaminergic and noradrenergic terminals are capable of packaging [(3)h]dopamine in a form allowing vesicle-mediated release; additionally, only the dopaminergic terminals have functional presynaptic nachrs that, when stimulated by nicotinic agonists, evoke [(3)h]dopamine release. |
2002-05-13 |
2023-08-12 |
mouse |
| Candice Drouin, Laurent Darracq, Fabrice Trovero, Gérard Blanc, Jacques Glowinski, Susanna Cotecchia, Jean-Pol Tassi. Alpha1b-adrenergic receptors control locomotor and rewarding effects of psychostimulants and opiates. The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 22. issue 7. 2002-04-08. PMID:11923452. |
because catecholamine tissue levels, autoradiography of d1 and d2 dopaminergic receptors, and of dopamine reuptake sites and locomotor response to a d1 agonist showed that basal dopaminergic transmission was similar in knock-out and wild-type mice, our data indicate a critical role of alpha1b-adrenergic receptors and noradrenergic transmission in the vulnerability to addiction. |
2002-04-08 |
2023-08-12 |
mouse |
| E C Wolter. Intrinsic and extrinsic psychosis in Parkinson's disease. Journal of neurology. vol 248 Suppl 3. 2002-03-27. PMID:11697684. |
these symptoms are caused by a progressive abnormal degeneration of the dopamine (da) producing cells in the substantia nigra (sn) and ventral tegmentum area (vta) in combination with an interindividual fluctuating degree of decay in the noradrenergic (locus coeruleus), cholinergic forebrain (nucleus basalis of meynert) and serotoninergic (dorsal raphe nuclei) systems. |
2002-03-27 |
2023-08-12 |
Not clear |